ArticleCureus2026
Microbiological Characteristics of Necrotizing Fasciitis at Sultan Qaboos University Hospital, Muscat, Oman: A Retrospective Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Necrotizing fasciitis is a life-threatening, rapidly progressing infection of the subcutaneous tissue and fascia. Diabetes mellitus, immunosuppression, and other comorbid conditions are primary predisposing factors. The lower limbs are the most commonly affected site. Necrotizing fasciitis is classified into two main microbiological categories: type I (polymicrobial infection), which is more prevalent, and type II (monomicrobial infection). Early clinical recognition, prompt surgical debridement, and timely initiation of appropriate empirical antimicrobial therapy are crucial for effective management. Methods A retrospective study was conducted over a five-year period (2015-2021), including adult patients (≥18 years) with a confirmed diagnosis of necrotizing fasciitis who had available clinical data and a follow-up period of 12 months. Clinical parameters, including comorbid conditions, infection sites, and management approaches (surgical and medical), were documented. Additionally, microbiological profiles and antimicrobial resistance patterns were analysed to determine their impact on 30-day mortality. Results A total of 43 patients were included, with 31 males (72%) and 12 females (28%), and a median age of 61 years (range: 18-85 years). Diabetes mellitus was the most prevalent comorbid condition, affecting 31 patients (72%). Lower limbs were involved in 31 cases (72%). Type I and type II infections were nearly equally distributed, accounting for 22 cases (51%) and 21 cases (49%), respectively. The predominant isolated organisms were
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.